Performance
LowHasn't faired well - amongst the low performers
Valuation
AvgCan be considered moderately valued vs the market
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
AvgThe stock has a moderate number of red flags
How to use scorecard? Learn more
—
—
—
Nectar Lifesciences Limited is a pharmaceutical company. The Company's operations include manufacturing and marketing of oral and sterile cephalosporin's, phytochemicals and allied products.
Customise key metrics, see detailed forecasts, download stock data and more
A significant proportion of promoter holdings is pledged
In last 3 months, mutual fund holding of the company has almost stayed constant
Nectar Lifesciences Limited has informed the Exchange regarding 'Dissolution of a Wholly Owned Subsidiary ( WOS ) of Nectar Lifesciences Limited ( Company ).'. | Download
Nectar Lifesciences Limited has informed the Exchange regarding 'Dissolution of a Wholly Owned Subsidiary ( WOS ) of Nectar Lifesciences Limited ( Company ).'. | Download
Nectar Lifesciences Limited has informed the Exchange regarding 'Minutes/ Proceedings of the Ordinary/ Special Resolutions passed by way of Postal Ballot'. | Download
Nectar Lifesciences Limited has informed the Exchange regarding 'Minutes/ Proceedings of the Ordinary/ Special Resolutions passed by way of Postal Ballot'. | Download
Final • Div/Share: ₹ 0.05
Decreased Total Promoter HoldingIncreasing promoter holding is considered good and reflects management’s positive view about the future outlook
In last 6 months, promoter holding in the company has decreased by 11.45%